155 related articles for article (PubMed ID: 12435795)
1. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.
Garrigues A; Loiseau N; Delaforge M; Ferté J; Garrigos M; André F; Orlowski S
Mol Pharmacol; 2002 Dec; 62(6):1288-98. PubMed ID: 12435795
[TBL] [Abstract][Full Text] [Related]
2. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
5. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.
Sharom FJ; Lu P; Liu R; Yu X
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):621-30. PubMed ID: 9677321
[TBL] [Abstract][Full Text] [Related]
6. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.
Aller SG; Yu J; Ward A; Weng Y; Chittaboina S; Zhuo R; Harrell PM; Trinh YT; Zhang Q; Urbatsch IL; Chang G
Science; 2009 Mar; 323(5922):1718-22. PubMed ID: 19325113
[TBL] [Abstract][Full Text] [Related]
7. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.
Sharom FJ; Yu X; DiDiodato G; Chu JW
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):421-8. PubMed ID: 8973548
[TBL] [Abstract][Full Text] [Related]
8. Dissection of drug-binding-induced conformational changes in P-glycoprotein.
Wang G; Pincheira R; Zhang JT
Eur J Biochem; 1998 Jul; 255(2):383-90. PubMed ID: 9716379
[TBL] [Abstract][Full Text] [Related]
9. Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet.
Qu Q; Sharom FJ
Biochemistry; 2002 Apr; 41(14):4744-52. PubMed ID: 11926837
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
Pajeva IK; Wiese M
J Med Chem; 2002 Dec; 45(26):5671-86. PubMed ID: 12477351
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores.
Sharom FJ; DiDiodato G; Yu X; Ashbourne KJ
J Biol Chem; 1995 Apr; 270(17):10334-41. PubMed ID: 7730340
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistance drug-binding peptides generated by using a phage display library.
Popkov M; Lussier I; Medvedkine V; Estève PO; Alakhov V; Mandeville R
Eur J Biochem; 1998 Jan; 251(1-2):155-63. PubMed ID: 9492279
[TBL] [Abstract][Full Text] [Related]
13. Selection and characterization of verapamil-resistant multidrug resistant cells.
Cano-Gauci DF; Seibert FS; Safa AR; Riordan JR
Biochem Biophys Res Commun; 1995 Apr; 209(2):497-505. PubMed ID: 7733917
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic fluorescence of the P-glycoprotein multidrug transporter: sensitivity of tryptophan residues to binding of drugs and nucleotides.
Liu R; Siemiarczuk A; Sharom FJ
Biochemistry; 2000 Dec; 39(48):14927-38. PubMed ID: 11101309
[TBL] [Abstract][Full Text] [Related]
15. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.
Ekins S; Kim RB; Leake BF; Dantzig AH; Schuetz EG; Lan LB; Yasuda K; Shepard RL; Winter MA; Schuetz JD; Wikel JH; Wrighton SA
Mol Pharmacol; 2002 May; 61(5):974-81. PubMed ID: 11961114
[TBL] [Abstract][Full Text] [Related]
16. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.
Pearce HL; Safa AR; Bach NJ; Winter MA; Cirtain MC; Beck WT
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5128-32. PubMed ID: 2567994
[TBL] [Abstract][Full Text] [Related]
17. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
Ferry D; Boer R; Callaghan R; Ulrich WR
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
[TBL] [Abstract][Full Text] [Related]
18. Mini review on molecular modeling of P-glycoprotein (Pgp).
Ha SN; Hochman J; Sheridan RP
Curr Top Med Chem; 2007; 7(15):1525-9. PubMed ID: 17897039
[TBL] [Abstract][Full Text] [Related]
19. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein.
Isenberg B; Thole H; Tümmler B; Demmer A
Eur J Biochem; 2001 May; 268(9):2629-34. PubMed ID: 11322883
[TBL] [Abstract][Full Text] [Related]
20. Lysine 268 adjacent to transmembrane helix 5 of hamster P-glycoprotein is the major photobinding site of iodomycin in CHO B30 cells.
Demmer A; Thole H; Raida M; Tümmler B
FEBS Open Bio; 2021 Apr; 11(4):1084-1092. PubMed ID: 33565718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
